nodes	percent_of_prediction	percent_of_DWPC	metapath
Aceprometazine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.0615	0.0646	CrCrCtD
Aceprometazine—Trimipramine—Carbamazepine—epilepsy syndrome	0.0601	0.0632	CrCrCtD
Aceprometazine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0575	0.0604	CrCrCtD
Aceprometazine—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.0554	0.0582	CrCrCtD
Aceprometazine—Methdilazine—Carbamazepine—epilepsy syndrome	0.054	0.0568	CrCrCtD
Aceprometazine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.053	0.0557	CrCrCtD
Aceprometazine—Clomipramine—Clobazam—epilepsy syndrome	0.0519	0.0545	CrCrCtD
Aceprometazine—Promethazine—Carbamazepine—epilepsy syndrome	0.051	0.0536	CrCrCtD
Aceprometazine—Chlorprothixene—Midazolam—epilepsy syndrome	0.0508	0.0534	CrCrCtD
Aceprometazine—Alimemazine—Carbamazepine—epilepsy syndrome	0.05	0.0526	CrCrCtD
Aceprometazine—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.0498	0.0523	CrCrCtD
Aceprometazine—Clomipramine—Diazepam—epilepsy syndrome	0.0482	0.0507	CrCrCtD
Aceprometazine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.047	0.0494	CrCrCtD
Aceprometazine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.0461	0.0485	CrCrCtD
Aceprometazine—Chlorpromazine—Clobazam—epilepsy syndrome	0.0459	0.0482	CrCrCtD
Aceprometazine—Chlorprothixene—Diazepam—epilepsy syndrome	0.0452	0.0476	CrCrCtD
Aceprometazine—Promazine—Carbamazepine—epilepsy syndrome	0.0431	0.0453	CrCrCtD
Aceprometazine—Prochlorperazine—Clobazam—epilepsy syndrome	0.0412	0.0433	CrCrCtD
Aceprometazine—Promazine—Oxcarbazepine—epilepsy syndrome	0.0397	0.0418	CrCrCtD
Aceprometazine—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000473	0.0485	CrCbGaD
Aceprometazine—Ethopropazine—CHRM1—epilepsy syndrome	0.000249	0.0255	CrCbGaD
Aceprometazine—Cyamemazine—CHRM2—epilepsy syndrome	0.00024	0.0246	CrCbGaD
Aceprometazine—Mequitazine—CHRM2—epilepsy syndrome	0.000208	0.0214	CrCbGaD
Aceprometazine—Levomethadyl Acetate—OPRM1—epilepsy syndrome	0.000206	0.0211	CrCbGaD
Aceprometazine—Propericiazine—ADRA2A—epilepsy syndrome	0.000205	0.021	CrCbGaD
Aceprometazine—Triflupromazine—CHRM1—epilepsy syndrome	0.000204	0.0209	CrCbGaD
Aceprometazine—Ethopropazine—CHRM2—epilepsy syndrome	0.000203	0.0208	CrCbGaD
Aceprometazine—Ethopropazine—BCHE—epilepsy syndrome	0.00017	0.0174	CrCbGaD
Aceprometazine—Triflupromazine—CHRM2—epilepsy syndrome	0.000167	0.0171	CrCbGaD
Aceprometazine—Propiomazine—CHRM3—epilepsy syndrome	0.000162	0.0166	CrCbGaD
Aceprometazine—Methadone—OPRD1—epilepsy syndrome	0.000158	0.0162	CrCbGaD
Aceprometazine—Chlorprothixene—CHRM3—epilepsy syndrome	0.000153	0.0157	CrCbGaD
Aceprometazine—Propiomazine—CHRM1—epilepsy syndrome	0.000151	0.0155	CrCbGaD
Aceprometazine—Mesoridazine—CHRM2—epilepsy syndrome	0.000146	0.015	CrCbGaD
Aceprometazine—Chlorprothixene—CHRM1—epilepsy syndrome	0.000143	0.0146	CrCbGaD
Aceprometazine—Prochlorperazine—CHRM2—epilepsy syndrome	0.000142	0.0145	CrCbGaD
Aceprometazine—Triflupromazine—BCHE—epilepsy syndrome	0.000139	0.0142	CrCbGaD
Aceprometazine—Methotrimeprazine—CHRM3—epilepsy syndrome	0.000138	0.0142	CrCbGaD
Aceprometazine—Promethazine—CHRM3—epilepsy syndrome	0.000136	0.014	CrCbGaD
Aceprometazine—Methotrimeprazine—CHRM1—epilepsy syndrome	0.000129	0.0132	CrCbGaD
Aceprometazine—Promethazine—CHRM1—epilepsy syndrome	0.000127	0.013	CrCbGaD
Aceprometazine—Propiomazine—CHRM2—epilepsy syndrome	0.000123	0.0126	CrCbGaD
Aceprometazine—Methadone—OPRM1—epilepsy syndrome	0.000121	0.0124	CrCbGaD
Aceprometazine—Cyamemazine—HTR2A—epilepsy syndrome	0.00012	0.0123	CrCbGaD
Aceprometazine—Promazine—CHRM3—epilepsy syndrome	0.00012	0.0123	CrCbGaD
Aceprometazine—Chlorprothixene—CHRM2—epilepsy syndrome	0.000117	0.012	CrCbGaD
Aceprometazine—Diltiazem—CYP2C19—epilepsy syndrome	0.000115	0.0118	CrCbGaD
Aceprometazine—Promazine—CHRM1—epilepsy syndrome	0.000112	0.0115	CrCbGaD
Aceprometazine—Thioridazine—CHRM2—epilepsy syndrome	0.00011	0.0113	CrCbGaD
Aceprometazine—Thioridazine—HTR7—epilepsy syndrome	0.00011	0.0113	CrCbGaD
Aceprometazine—Fluphenazine—ADRA2A—epilepsy syndrome	0.000109	0.0112	CrCbGaD
Aceprometazine—Chlorpromazine—CHRM3—epilepsy syndrome	0.000106	0.0108	CrCbGaD
Aceprometazine—Methotrimeprazine—CHRM2—epilepsy syndrome	0.000105	0.0108	CrCbGaD
Aceprometazine—Promethazine—CHRM2—epilepsy syndrome	0.000104	0.0106	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—CHRM3—epilepsy syndrome	0.000104	0.00267	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	0.000104	0.00267	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—ACKR4—epilepsy syndrome	0.000102	0.00264	CbGpPWpGaD
Aceprometazine—Trifluoperazine—CHRM2—epilepsy syndrome	0.000102	0.0105	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—SSTR4—epilepsy syndrome	0.000102	0.00263	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—SSTR5—epilepsy syndrome	0.000102	0.00263	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	0.000102	0.00262	CbGpPWpGaD
Aceprometazine—Perphenazine—HTR7—epilepsy syndrome	0.000101	0.0103	CrCbGaD
Aceprometazine—Clomipramine—ADRA2A—epilepsy syndrome	0.0001	0.0102	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—CX3CR1—epilepsy syndrome	9.94e-05	0.00256	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	9.92e-05	0.00255	CbGpPWpGaD
Aceprometazine—Chlorpromazine—CHRM1—epilepsy syndrome	9.84e-05	0.0101	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—CCR10—epilepsy syndrome	9.78e-05	0.00252	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—CX3CL1—epilepsy syndrome	9.75e-05	0.00251	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—BDKRB1—epilepsy syndrome	9.75e-05	0.00251	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—CHRM2—epilepsy syndrome	9.75e-05	0.00251	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	9.66e-05	0.00249	CbGpPWpGaD
Aceprometazine—Mequitazine—CYP2D6—epilepsy syndrome	9.53e-05	0.00977	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—GABBR1—epilepsy syndrome	9.49e-05	0.00244	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	9.44e-05	0.00243	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	9.44e-05	0.00243	CbGpPWpGaD
Aceprometazine—Thioridazine—ADRA2A—epilepsy syndrome	9.42e-05	0.00965	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—SSTR5—epilepsy syndrome	9.27e-05	0.00239	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—SSTR4—epilepsy syndrome	9.27e-05	0.00239	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	9.24e-05	0.00238	CbGpPWpGaD
Aceprometazine—Trimipramine—ADRA2A—epilepsy syndrome	9.2e-05	0.00943	CrCbGaD
Aceprometazine—Pipotiazine—CYP2C19—epilepsy syndrome	9.15e-05	0.00937	CrCbGaD
Aceprometazine—Promazine—CHRM2—epilepsy syndrome	9.13e-05	0.00936	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—HRH3—epilepsy syndrome	9.1e-05	0.00234	CbGpPWpGaD
Aceprometazine—Methotrimeprazine—ADRA2A—epilepsy syndrome	8.99e-05	0.00921	CrCbGaD
Aceprometazine—HRH1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	8.99e-05	0.00231	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—OPRM1—epilepsy syndrome	8.95e-05	0.0023	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CCR10—epilepsy syndrome	8.89e-05	0.00229	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	8.88e-05	0.00228	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	8.88e-05	0.00228	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	8.71e-05	0.00224	CbGpPWpGaD
Aceprometazine—Perphenazine—ADRA2A—epilepsy syndrome	8.64e-05	0.00886	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—GRM2—epilepsy syndrome	8.55e-05	0.0022	CbGpPWpGaD
Aceprometazine—Diltiazem—CYP2D6—epilepsy syndrome	8.55e-05	0.00876	CrCbGaD
Aceprometazine—HRH1—G alpha (q) signalling events—AGT—epilepsy syndrome	8.53e-05	0.0022	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	8.5e-05	0.00219	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—CCR3—epilepsy syndrome	8.46e-05	0.00218	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—NPY—epilepsy syndrome	8.24e-05	0.00212	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	8.04e-05	0.00207	CbGpPWpGaD
Aceprometazine—Chlorpromazine—CHRM2—epilepsy syndrome	8.03e-05	0.00823	CrCbGaD
Aceprometazine—Chlorpromazine—HTR7—epilepsy syndrome	8e-05	0.00819	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—OXT—epilepsy syndrome	7.95e-05	0.00205	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—CXCL2—epilepsy syndrome	7.95e-05	0.00205	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—CRH—epilepsy syndrome	7.95e-05	0.00205	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—CCL3—epilepsy syndrome	7.95e-05	0.00205	CbGpPWpGaD
Aceprometazine—Promazine—ADRA2A—epilepsy syndrome	7.79e-05	0.00799	CrCbGaD
Aceprometazine—HRH1—IL-4 Signaling Pathway—AKT1—epilepsy syndrome	7.77e-05	0.002	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GRM2—epilepsy syndrome	7.77e-05	0.002	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—SSTR3—epilepsy syndrome	7.73e-05	0.00199	CbGpPWpGaD
Aceprometazine—Acepromazine—HTR2A—epilepsy syndrome	7.71e-05	0.0079	CrCbGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	7.63e-05	0.00196	CbGpPWpGaD
Aceprometazine—Clomipramine—SLC6A4—epilepsy syndrome	7.63e-05	0.00782	CrCbGaD
Aceprometazine—Thioproperazine—HTR2A—epilepsy syndrome	7.54e-05	0.00772	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	7.42e-05	0.00191	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CCR8—epilepsy syndrome	7.42e-05	0.00191	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—SSTR1—epilepsy syndrome	7.42e-05	0.00191	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CCR9—epilepsy syndrome	7.42e-05	0.00191	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—NPY2R—epilepsy syndrome	7.42e-05	0.00191	CbGpPWpGaD
Aceprometazine—Pipotiazine—HTR2A—epilepsy syndrome	7.41e-05	0.0076	CrCbGaD
Aceprometazine—Mesoridazine—HTR2A—epilepsy syndrome	7.32e-05	0.0075	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—GRM4—epilepsy syndrome	7.27e-05	0.00187	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—GRM3—epilepsy syndrome	7.27e-05	0.00187	CbGpPWpGaD
Aceprometazine—Clomipramine—CYP2C19—epilepsy syndrome	7.23e-05	0.00741	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—SST—epilepsy syndrome	7.19e-05	0.00185	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—CCR2—epilepsy syndrome	7.19e-05	0.00185	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	7.16e-05	0.00184	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—SSTR2—epilepsy syndrome	7.14e-05	0.00184	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	7.1e-05	0.00183	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—ADRA2A—epilepsy syndrome	7.04e-05	0.00181	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—SSTR3—epilepsy syndrome	7.02e-05	0.00181	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	7.02e-05	0.00181	CbGpPWpGaD
Aceprometazine—Trimipramine—SLC6A4—epilepsy syndrome	7.02e-05	0.00719	CrCbGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	6.95e-05	0.00179	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	6.93e-05	0.00178	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PRDM4—epilepsy syndrome	6.93e-05	0.00178	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	6.89e-05	0.00177	CbGpPWpGaD
Aceprometazine—Chlorpromazine—ADRA2A—epilepsy syndrome	6.86e-05	0.00703	CrCbGaD
Aceprometazine—Thioridazine—CYP2C19—epilepsy syndrome	6.81e-05	0.00698	CrCbGaD
Aceprometazine—Pipotiazine—CYP2D6—epilepsy syndrome	6.78e-05	0.00695	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	6.76e-05	0.00174	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	6.76e-05	0.00174	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	6.73e-05	0.00173	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	6.73e-05	0.00173	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	6.73e-05	0.00173	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	6.73e-05	0.00173	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	6.73e-05	0.00173	CbGpPWpGaD
Aceprometazine—Chlorpromazine—BCHE—epilepsy syndrome	6.7e-05	0.00687	CrCbGaD
Aceprometazine—Mesoridazine—CYP2D6—epilepsy syndrome	6.69e-05	0.00686	CrCbGaD
Aceprometazine—Trimipramine—CYP2C19—epilepsy syndrome	6.65e-05	0.00682	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	6.64e-05	0.00171	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	6.6e-05	0.0017	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	6.6e-05	0.0017	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	6.58e-05	0.00169	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	6.48e-05	0.00167	CbGpPWpGaD
Aceprometazine—Prochlorperazine—CYP2D6—epilepsy syndrome	6.48e-05	0.00664	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	6.47e-05	0.00167	CbGpPWpGaD
Aceprometazine—Fluphenazine—HTR2A—epilepsy syndrome	6.41e-05	0.00657	CrCbGaD
Aceprometazine—Methadone—CYP2C19—epilepsy syndrome	6.31e-05	0.00646	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	6.31e-05	0.00162	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	6.31e-05	0.00162	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	6.31e-05	0.00162	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	6.31e-05	0.00162	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	6.26e-05	0.00161	CbGpPWpGaD
Aceprometazine—Perphenazine—CYP2C19—epilepsy syndrome	6.25e-05	0.00641	CrCbGaD
Aceprometazine—Propiomazine—HTR2A—epilepsy syndrome	6.16e-05	0.00632	CrCbGaD
Aceprometazine—Diltiazem—ABCB1—epilepsy syndrome	6.11e-05	0.00626	CrCbGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	6.08e-05	0.00157	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	6.05e-05	0.00156	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	5.97e-05	0.00154	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	5.97e-05	0.00154	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	5.95e-05	0.00153	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	5.93e-05	0.00153	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	5.86e-05	0.00151	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	5.86e-05	0.00151	CbGpPWpGaD
Aceprometazine—Clomipramine—HTR2A—epilepsy syndrome	5.86e-05	0.00601	CrCbGaD
Aceprometazine—Fluphenazine—CYP2D6—epilepsy syndrome	5.86e-05	0.00601	CrCbGaD
Aceprometazine—Chlorprothixene—HTR2A—epilepsy syndrome	5.84e-05	0.00598	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	5.73e-05	0.00147	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	5.73e-05	0.00147	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	5.73e-05	0.00147	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	5.73e-05	0.00147	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	5.65e-05	0.00145	CbGpPWpGaD
Aceprometazine—Promazine—CYP2C19—epilepsy syndrome	5.63e-05	0.00577	CrCbGaD
Aceprometazine—Thioridazine—HTR2A—epilepsy syndrome	5.52e-05	0.00566	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	5.51e-05	0.00142	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	5.51e-05	0.00142	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	5.48e-05	0.00141	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	5.48e-05	0.00141	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	5.45e-05	0.0014	CbGpPWpGaD
Aceprometazine—Triflupromazine—ABCB1—epilepsy syndrome	5.44e-05	0.00558	CrCbGaD
Aceprometazine—Trimipramine—HTR2A—epilepsy syndrome	5.39e-05	0.00553	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	5.38e-05	0.00139	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	5.36e-05	0.00138	CbGpPWpGaD
Aceprometazine—Clomipramine—CYP2D6—epilepsy syndrome	5.36e-05	0.00549	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	5.32e-05	0.00137	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	5.32e-05	0.00137	CbGpPWpGaD
Aceprometazine—Acepromazine—ALB—epilepsy syndrome	5.28e-05	0.00541	CrCbGaD
Aceprometazine—Methotrimeprazine—HTR2A—epilepsy syndrome	5.27e-05	0.0054	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	5.25e-05	0.00135	CbGpPWpGaD
Aceprometazine—Promethazine—HTR2A—epilepsy syndrome	5.19e-05	0.00532	CrCbGaD
Aceprometazine—Thioproperazine—ALB—epilepsy syndrome	5.16e-05	0.00529	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	5.14e-05	0.00132	CbGpPWpGaD
Aceprometazine—Trifluoperazine—HTR2A—epilepsy syndrome	5.12e-05	0.00525	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	5.1e-05	0.00131	CbGpPWpGaD
Aceprometazine—Pipotiazine—ALB—epilepsy syndrome	5.07e-05	0.0052	CrCbGaD
Aceprometazine—Perphenazine—HTR2A—epilepsy syndrome	5.07e-05	0.00519	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	5.06e-05	0.0013	CbGpPWpGaD
Aceprometazine—Thioridazine—CYP2D6—epilepsy syndrome	5.05e-05	0.00517	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	5e-05	0.00129	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	5e-05	0.00129	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	5e-05	0.00129	CbGpPWpGaD
Aceprometazine—Trimipramine—CYP2D6—epilepsy syndrome	4.93e-05	0.00505	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	4.87e-05	0.00125	CbGpPWpGaD
Aceprometazine—Methotrimeprazine—CYP2D6—epilepsy syndrome	4.82e-05	0.00494	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	4.78e-05	0.00123	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	4.76e-05	0.00122	CbGpPWpGaD
Aceprometazine—Promethazine—CYP2D6—epilepsy syndrome	4.75e-05	0.00487	CrCbGaD
Aceprometazine—Methadone—CYP2D6—epilepsy syndrome	4.68e-05	0.00479	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	4.67e-05	0.0012	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	4.66e-05	0.0012	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	4.65e-05	0.0012	CbGpPWpGaD
Aceprometazine—Perphenazine—CYP2D6—epilepsy syndrome	4.63e-05	0.00475	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	4.63e-05	0.00119	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	4.6e-05	0.00118	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	4.59e-05	0.00118	CbGpPWpGaD
Aceprometazine—Promazine—HTR2A—epilepsy syndrome	4.57e-05	0.00468	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	4.53e-05	0.00117	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	4.49e-05	0.00116	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	4.49e-05	0.00116	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	4.49e-05	0.00116	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	4.34e-05	0.00112	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	4.3e-05	0.00111	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	4.23e-05	0.00109	CbGpPWpGaD
Aceprometazine—Fluphenazine—ABCB1—epilepsy syndrome	4.18e-05	0.00429	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	4.15e-05	0.00107	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	4.08e-05	0.00105	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	4.08e-05	0.00105	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	4.08e-05	0.00105	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	4.08e-05	0.00105	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	4.06e-05	0.00105	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	4.06e-05	0.00105	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	4.06e-05	0.00105	CbGpPWpGaD
Aceprometazine—Chlorpromazine—HTR2A—epilepsy syndrome	4.02e-05	0.00412	CrCbGaD
Aceprometazine—Clomipramine—ALB—epilepsy syndrome	4.01e-05	0.00411	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.98e-05	0.00102	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	3.98e-05	0.00102	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	3.98e-05	0.00102	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	3.98e-05	0.00102	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	3.98e-05	0.00102	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.98e-05	0.00102	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	3.9e-05	0.001	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	3.9e-05	0.001	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	3.83e-05	0.000986	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	3.83e-05	0.000986	CbGpPWpGaD
Aceprometazine—Clomipramine—ABCB1—epilepsy syndrome	3.83e-05	0.00392	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.82e-05	0.000983	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.82e-05	0.000983	CbGpPWpGaD
Aceprometazine—Chlorprothixene—ABCB1—epilepsy syndrome	3.81e-05	0.00391	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	3.75e-05	0.000965	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.74e-05	0.000962	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	3.7e-05	0.000952	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PGF—epilepsy syndrome	3.7e-05	0.000952	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	3.69e-05	0.00095	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—SST—epilepsy syndrome	3.69e-05	0.00095	CbGpPWpGaD
Aceprometazine—Chlorpromazine—CYP2D6—epilepsy syndrome	3.68e-05	0.00377	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	3.66e-05	0.000942	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	3.62e-05	0.000932	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.61e-05	0.000929	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	3.54e-05	0.000912	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	3.53e-05	0.000908	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	3.53e-05	0.000908	CbGpPWpGaD
Aceprometazine—Trimipramine—ABCB1—epilepsy syndrome	3.52e-05	0.00361	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	3.49e-05	0.000897	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.47e-05	0.000893	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	3.47e-05	0.000893	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	3.41e-05	0.000876	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	3.39e-05	0.000873	CbGpPWpGaD
Aceprometazine—Promethazine—ABCB1—epilepsy syndrome	3.39e-05	0.00348	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	3.38e-05	0.000871	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	3.38e-05	0.000871	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	3.38e-05	0.000871	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	3.38e-05	0.000871	CbGpPWpGaD
Aceprometazine—Trifluoperazine—ABCB1—epilepsy syndrome	3.35e-05	0.00343	CrCbGaD
Aceprometazine—Methadone—ABCB1—epilepsy syndrome	3.34e-05	0.00342	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	3.32e-05	0.000855	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	3.23e-05	0.00083	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	3.18e-05	0.000819	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GAL—epilepsy syndrome	3.18e-05	0.000819	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	3.18e-05	0.000819	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	3.17e-05	0.000815	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	3.14e-05	0.000809	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	3.14e-05	0.000809	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	3.14e-05	0.000809	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	3.08e-05	0.000793	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	3.01e-05	0.000776	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	2.96e-05	0.000761	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.96e-05	0.000761	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.96e-05	0.000761	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	2.89e-05	0.000743	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	2.88e-05	0.00074	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	2.8e-05	0.00072	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	2.76e-05	0.00071	CbGpPWpGaD
Aceprometazine—Chlorpromazine—ALB—epilepsy syndrome	2.75e-05	0.00282	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	2.71e-05	0.000699	CbGpPWpGaD
Aceprometazine—Chlorpromazine—ABCB1—epilepsy syndrome	2.63e-05	0.00269	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.62e-05	0.000674	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	2.56e-05	0.00066	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.56e-05	0.000659	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	2.5e-05	0.000643	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.5e-05	0.000643	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	2.43e-05	0.000626	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	2.41e-05	0.00062	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	2.41e-05	0.00062	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	2.41e-05	0.00062	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	2.41e-05	0.00062	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	2.41e-05	0.00062	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	2.38e-05	0.000612	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.33e-05	0.000599	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.25e-05	0.000578	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	2.24e-05	0.000577	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	2.24e-05	0.000577	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	2.21e-05	0.000568	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	2.18e-05	0.000561	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	2.18e-05	0.000561	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—SST—epilepsy syndrome	2.18e-05	0.000561	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	2.16e-05	0.000556	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.13e-05	0.000549	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	2.12e-05	0.000547	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	2.05e-05	0.000527	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	2.05e-05	0.000527	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	2.05e-05	0.000527	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	2.04e-05	0.000525	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	2.03e-05	0.000523	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	2.01e-05	0.000518	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	2.01e-05	0.000518	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	2e-05	0.000516	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	1.96e-05	0.000505	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	1.91e-05	0.00049	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	1.87e-05	0.000481	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	1.86e-05	0.000478	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	1.83e-05	0.00047	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	1.82e-05	0.000468	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	1.73e-05	0.000445	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	1.71e-05	0.00044	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	1.71e-05	0.000439	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.65e-05	0.000425	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.56e-05	0.000402	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.52e-05	0.000391	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.51e-05	0.00039	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.51e-05	0.000389	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.46e-05	0.000376	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.44e-05	0.000372	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.4e-05	0.000361	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.37e-05	0.000354	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.31e-05	0.000336	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.3e-05	0.000336	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.28e-05	0.000329	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.25e-05	0.000322	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.21e-05	0.00031	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.2e-05	0.000309	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	1.1e-05	0.000283	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	1.07e-05	0.000276	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	9.71e-06	0.00025	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	9.01e-06	0.000232	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	8.84e-06	0.000227	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.2e-06	0.000211	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	8.13e-06	0.000209	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	7.89e-06	0.000203	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	7.68e-06	0.000198	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	7.45e-06	0.000192	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	7.08e-06	0.000182	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	6.9e-06	0.000178	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	4.4e-06	0.000113	CbGpPWpGaD
